AGRX Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 20:55):

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States...

Stats
Tagesvolumen	55 109.00
Durchschnittsvolumen	731 669
Marktkapitalisierung	2.86M
EPS	$-1.510 ( 2024-03-28 )
Nächstes Ertragsdatum	( $-0.510 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0600
ATR14	$0.0130 (3.12%)

Insider Trading

Date	Person	Action	Amount	type
2023-10-03	Coiante Scott M	Buy	20 000	Common Stock
2023-08-16	Coiante Scott M	Sell	0	Common Stock
2023-06-28	Welsh Amy	Buy	13 500	Common Stock
2023-06-28	Welsh Amy	Buy	4 500	Employee Stock Option (Right to Buy)
2023-06-28	Korner Paul	Buy	13 500	Common Stock

INSIDER POWER
99.59
Last 98 transactions
Buy: 13 666 273 \| Sell: 187 248

Agile Therapeutics Inc Korrelation

10 Am meisten positiv korreliert
PXS	0.967
IONM	0.964
IVAC	0.959
KPTI	0.958
KPRX	0.953
ENTA	0.952
AACG	0.952
NSTG	0.948
RVSN	0.947
PRQR	0.947

10 Am meisten negativ korreliert
VRSK	-0.961
EVLV	-0.953
BTWN	-0.952
QTRX	-0.949
PKOH	-0.946
IMTX	-0.944
PRSR	-0.938
SPNS	-0.936
MDRRP	-0.935
AMZN	-0.933

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Agile Therapeutics Inc Finanzdaten

Annual	2023
Umsatz:	$19.59M
Bruttogewinn:	$10.62M (54.18 %)
EPS:	$-0.00670

FY	2023
Umsatz:	$19.59M
Bruttogewinn:	$10.62M (54.18 %)
EPS:	$-0.00670

FY	2022
Umsatz:	$10.88M
Bruttogewinn:	$4.05M (37.19 %)
EPS:	$-58.79

FY	2021
Umsatz:	$4.10M
Bruttogewinn:	$-6.62M (-161.35 %)
EPS:	$-0.884

Financial Reports:

No articles found.

Agile Therapeutics Inc

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.